Skip to main content
Caplight Logo









Epilert

Epilert

Private
TunisiaHealthcare & Life Scienceshttps://epilert.io

Company Overview

Epilert operates in Healthcare & Life Sciences and is based in Tunisia. It was founded in 2017.

Epilert is a Tunisian medtech company founded in 2017 that developed a smart bracelet to detect epileptic seizures and alert caregivers. The company appears to be inactive or has evolved into a new entity named Knowlepsy, as the original website is defunct and a co-founder is now associated with Knowlepsy.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Consumer Electronics

Business Model

B2B2C

Customer Profile

Hardware + Subscription, Hardware Sales

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Epilert Comparables

Compare Epilert with similar companies based on industry and business-model similarity.

Epilert comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
monikit
86%
Neurava
82%
Quadlytics Inc.
80%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Epilert Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for Epilert. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Epilert Filings

Explore SEC and related filing metadata, where available.

Epilert filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Epilert's valuation, stock price, and market status.

Is Epilert a public or private company?

Epilert is a private company.

What is the current stock price of Epilert?

Epilert is a private company, so its shares have no public market price. Caplight tracks Epilert's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Epilert worth (valuation)?

Valuation information for Epilert is not publicly available.

Can I buy Epilert stock?

Epilert shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Epilert's last funding round?

Funding round information for Epilert is not publicly available.

Who are the main investors in Epilert?

Investor information for Epilert is not publicly disclosed.

Will Epilert IPO soon?

No public IPO plans have been announced for Epilert.

How can I track Epilert secondary market activity?

Caplight tracks bids, offers, and trades in Epilert's shares on secondary markets.

Firmographic Details

HeadquartersTunisia
Year Founded2017
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?